Estrella Immunopharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -5,544 | -2,104 | -3,376 |
EBIT | -5,544 | -2,104 | -3,376 |
Net Income | -5,544 | -2,104 | -3,376 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -414 | -465 | -2,217 |
Cash | 1,316 | 421 | 1,797 |
Basic Shares | 36,165 | 36,188 | 36,208 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -915 | -1,685 | |
EBIT | -7,310 | -1,143 | -1,685 |
Net Income | -7,311 | -996 | -1,685 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -16,068 | -1,043 | -1,442 |
Cash | 4,165 | 40 | 4,088 |
Basic Shares | 36,289 | 5,762 | 5,849 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.15 |
2025-03-31 | -$0.06 |
2024-12-31 | -$0.03 |
2024-09-30 | -$0.09 |
